SE
58
-2
EXR
24
-4
AMGN
31
-3
PSA
48
10
MLM
60
-3
BAX
38
-3
EFX
49
-5
MS
72
-2
GRMN
34
-6
RSG
44
-4
PH
60
-4
MU
75
-3
IVZ
60
-2
ADSK
59
-2
FFIV
47
-3
V
48
-4
EMR
60
-7
EXPD
43
-2
AMZN
53
-4
MDLZ
26
-6
SE
58
-2
EXR
24
-4
AMGN
31
-3
PSA
48
10
MLM
60
-3
BAX
38
-3
EFX
49
-5
MS
72
-2
GRMN
34
-6
RSG
44
-4
PH
60
-4
MU
75
-3
IVZ
60
-2
ADSK
59
-2
FFIV
47
-3
V
48
-4
EMR
60
-7
EXPD
43
-2
AMZN
53
-4
MDLZ
26
-6
Financhill
Back

YieldMax MRNA Option Income Strategy ETF Stock Predictions

Get Paid In ANY Crypto Market

Learn the crash-proof system. Watch the free training.
Sell
30

MRNY
YieldMax MRNA Option Income Strategy ETF

Last Price:
$15.07
Seasonality Move:
-21.08%

7 Day Trial

ALL ACCESS PASS

$ 7

Washington Wants Your Money. Here's How to Opt Out.

Learn how to become your own bank. Watch the free training.

YieldMax MRNA Option Income Strategy ETF Stock Forecast

  • Over the next 52 weeks, YieldMax MRNA Option Income Strategy ETF has on average historically fallen by 72.4% based on the past 2 years of stock performance.
  • YieldMax MRNA Option Income Strategy ETF has fallen lower in 2 of those 2 years over the subsequent 52-week period, corresponding to a historical accuracy of 100%
  • Is YieldMax MRNA Option Income Strategy ETF Stock Undervalued?
    The current YieldMax MRNA Option Income Strategy ETF [MRNY] share price is $14.70. The Score for MRNY is 30, which is 40% below its historic median score of 50, and infers higher risk than normal.
  • MRNY is currently trading in the 20-30% percentile range relative to its historical Stock Score levels.

Will YieldMax MRNA Option Income Strategy ETF Stock Go Up Next Year?

  • Over the next 52 weeks, YieldMax MRNA Option Income Strategy ETF has on average historically fallen by 72.4% based on the past 2 years of stock performance.

YieldMax MRNA Option Income Strategy ETF Stock Rating

Sell
30
YieldMax MRNA Option Income Strategy ETF (MRNY) is a Sell

Is YieldMax MRNA Option Income Strategy ETF overpriced?

  • YieldMax MRNA Option Income Strategy ETF has fallen lower in 2 of those 2 years over the subsequent 52-week period, corresponding to a historical accuracy of 100%

YieldMax MRNA Option Income Strategy ETF Stock Price History

Is MRNY stock going to rise?

  • Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and MRNY is experiencing slight selling pressure.

Stock Information

Stock Info

Exchange:
NYSEARCA
Country:
Industry:
Sector:
Type:
etf
Website:

52-Week Data

52-Week High:
56.65
52-Week Low:
13.60

Prediction Charts

Market Cap:
0
Price in USD:
14.70
Volume:
162K
Beta:
0.33

Technical Analysis

SMA50:
15.57
SMA100:
16.80
SMA200:
21.09
52-Wk Change:
-72.05%

Stock Predictions

  • Is YieldMax MRNA Option Income Strategy ETF stock public?
    Yes, YieldMax MRNA Option Income Strategy ETF is a publicly traded company.
  • What is the YieldMax MRNA Option Income Strategy ETF stock quote today?
    The YieldMax MRNA Option Income Strategy ETF stock price is 14.70 USD today.
  • How to buy YieldMax MRNA Option Income Strategy ETF stock online?
    You can buy YieldMax MRNA Option Income Strategy ETF shares by opening an account at a top tier brokerage firm, such as TD Ameritrade or tastyworks.

14-Day Historical Data

Date Opening Closing Minimum Maximum
Dec-10 15.47 15.71 15.75 15.46
Dec-11 15.50 15.70 15.71 15.50
Dec-12 15.64 15.63 15.95 15.59
Dec-15 15.55 15.79 15.91 15.35
Dec-16 15.79 15.85 15.85 15.52
Dec-17 15.87 16.08 16.37 15.86
Dec-18 15.90 15.81 16.25 15.80
Dec-19 15.84 16.91 17.07 15.84
Dec-22 16.81 17.32 17.81 16.75
Dec-24 16.31 16.50 16.50 16.31
Dec-26 16.03 15.50 16.04 15.42
Dec-29 15.31 15.43 15.48 15.29
Dec-30 15.51 15.13 15.51 15.07
Dec-31 15.11 14.70 15.11 14.48

YieldMax MRNA Option Income Strategy ETF Earnings

Data Unavailable

YieldMax MRNA Option Income Strategy ETF Forecast Revenue Growth

Data Unavailable

* YieldMax MRNA Option Income Strategy ETF stock forecasts short-term for next days and weeks may differ from long term prediction for next month and year based on timeline differences.